Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide

By Bechtold David A.   Yue Xu   Evans Richard M.   Davies Meirion   Gregson Norman A.   Smith Kenneth J.  

Brain, Vol. 128, Iss. 1, 2005-01 ,pp. : 18-28

Oxford University Press

Access to resources Recommend Favorite

Co‐localization of sodium channel Na v 1.6 and the sodium–calcium exchanger at sites of axonal injury in the spinal cord in EAE

By Craner Matthew J.   Hains Bryan C.   Lo Albert C.   Black Joel A.   Waxman Stephen G.  

Brain, Vol. 127, Iss. 2, 2004-02 ,pp. : 294-303

Oxford University Press

Access to resources Recommend Favorite

Do sodium channel blockers have neuroprotective effect after onset of ischemic insult?

By Ates Ozkan   Cayli Suleyman R.   Gurses Iclal   Karabulut Aysun Bay   Yucel Neslihan   Kocak Ayhan   Cakir Celal Ozbek   Yologlu Saim  

Neurological Research, Vol. 29, Iss. 3, 2007-04 ,pp. : 317-323

Maney Publishing

Access to resources Recommend Favorite

Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage

By Kanai Kazuaki   Kuwabara Satoshi   Misawa Sonoko   Tamura Noriko   Ogawara Kazue   Nakata Miho   Sawai Setsu   Hattori Takamichi   Bostock Hugh  

Brain, Vol. 129, Iss. 4, 2006-04 ,pp. : 953-962

Oxford University Press

Access to resources Recommend Favorite

Neuroinflammatory perspectives on the two faces of Alzheimer’s disease

By Eikelenboom P.   van Gool W. A.  

Journal of Neural Transmission, Vol. 111, Iss. 3, 2004-03 ,pp. : 281-294

Springer Publishing Company

Access to resources Recommend Favorite